EE484 Evaluating the Cost-Effectiveness of Dabrafenib and Trametinib for the Treatment of Pediatric Patients With Relapsed or Refractory High-Grade Glioma in England and Wales
Abstract
Authors
R Rafia M Ibrahim N Kane M Mushtaq J Mistry R Bains V Daisy A Casanova S Mondal G Partha D Hargrave LV Marshall K Jameson